Literature DB >> 30704624

Potential protective effects of red yeast rice in endothelial function against atherosclerotic cardiovascular disease.

Shu-Jun Feng1, Zhi-Han Tang2, Ying Wang3, Xin-Ying Tang1, Tao-Hua Li4, Wei Tang5, Ze-Min Kuang6.   

Abstract

Atherosclerotic cardiovascular disease (ASCVD) is the deadliest disease in the world, with endothelial injury occurring throughout the course of the disease. Therefore, improvement in endothelial function is of essential importance in the prevention of ASCVD. Red yeast rice (RYR), a healthy traditional Chinese food, has a lipid modulation function and also plays a vital role in the improvement of endothelial reactivity and cardiovascular protection; thus, it is significant in the prevention and treatment of ASCVD. This article reviews the molecular mechanisms of RYR and its related products in the improvement of endothelial function in terms of endothelial reactivity, anti-apoptosis of endothelial progenitor cells, oxidative stress alleviation and anti-inflammation.
Copyright © 2019 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerotic cardiovascular disease; Endothelial cells; Molecular mechanism; Red yeast rice; Xuezhikang

Mesh:

Substances:

Year:  2019        PMID: 30704624     DOI: 10.1016/S1875-5364(19)30009-3

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  2 in total

1.  A double-blind, placebo-controlled clinical trial to assess the effects of a combined nutraceutical on endothelial function in patients with mild-to-moderate hypercholesterolaemia.

Authors:  Valerio Pecchioli; Arrigo F G Cicero; Nazareno Lomartire; Maria P Gemmiti; Antonello Colangeli; Rosanna Germanò; Maria Pia Corsi; Giuseppe I W Germanò
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-05-07

2.  Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis.

Authors:  Wei Qin; Longyin Zhang; Zhange Li; Dan Xiao; Yue Zhang; Haiying Zhang; Justine Nyakango Mokembo; Seth Mikaye Monayo; Nabanit Kumar Jha; Philipp Kopylov; Dmitri Shchekochikhin; Yong Zhang
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.